MedPath

POTASSIUM PHOSPHATES INJECTION, USP

POTASSIUM PHOSPHATES INJECTION, USP

Approved
DIN Number

02139545

Drug Class

Human

Market Date

Dec 31, 1984

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02139545
AIG Number0207483001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA06 POTASSIUM PHOS INCL COMB W/0TH POT. SALTS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

POTASSIUM PHOSPHATE DIBASICActive
Strength: 236 MG / ML
Monograph: POTASSIUM PHOSPHATE DIBASIC
POTASSIUM PHOSPHATE MONOBASICActive
Strength: 224 MG / ML
Monograph: POTASSIUM PHOSPHATE MONOBASIC

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.